Home | Business News | Browse by Publication | T | Trial

Terminally ill have 'fundamental right' to unapproved drugs.

Publication: Trial
Publication Date: 01-JUL-06 		Format: Online
Delivery: Immediate Online Access
Full Article Title: Terminally ill have 'fundamental right' to unapproved drugs.(Washington, D.C.)

Article Excerpt
In a decision many lawyers believe will end up before the Supreme Court, the District of Columbia Circuit has ruled, 2-1, that terminally ill patients have a "fundamental right" guaranteed by the Due Process Clause of the Constitution to obtain experimental drugs that have not been fully approved by the FDA. (Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 445 F.3d 470 (D.C. Cir. 2006).)

The decision reinstates a lawsuit that sought to enjoin the FDA from barring the sale of post-Phase I investigational new drugs--those considered safe for expanded human testing--to terminally ill patients who...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.